Literature DB >> 14738652

A pilot study of 'fast track' antenatal screening for haemoglobinopathies.

J Wright1, N Rati, A Kennefick, A Cobley, C McKweon, A Wood.   

Abstract

The NHS Plan launched in 2000 advocated a linked antenatal and neonatal screening programme for haemoglobinopathies. Currently screening practices vary widely across the UK and patient sampling is generally performed in a hospital setting. The process is flawed and frequently fails to provide accurate and timely information. In this study we demonstrate that organisational changes can improve the efficiency and quality of screening. The primary care screening process described here has increased partner testing rates and allowed early identification of at risk couples.

Entities:  

Mesh:

Year:  2003        PMID: 14738652     DOI: 10.1258/096914103771773249

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  4 in total

1.  Haemoglobinopathy screening: an end to institutional racism?

Authors:  Theresa Marteau; Elizabeth Dormandy
Journal:  Br J Gen Pract       Date:  2005-06       Impact factor: 5.386

2.  Delay between pregnancy confirmation and sickle cell and [corrected] thalassaemia screening: a population-based cohort study.

Authors:  Elizabeth Dormandy; Martin C Gulliford; Erin P Reid; Katrina Brown; Theresa M Marteau
Journal:  Br J Gen Pract       Date:  2008-03       Impact factor: 5.386

3.  Antenatal haemoglobinopathy screening - Experiences of a large Australian Centre.

Authors:  Sylvia Ai; Corrina Cliffe; Giselle Kidson-Gerber
Journal:  Obstet Med       Date:  2020-08-19

4.  Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial.

Authors:  Elizabeth Dormandy; Martin Gulliford; Stirling Bryan; Tracy E Roberts; Michael Calnan; Karl Atkin; Jonathan Karnon; Jane Logan; Fred Kavalier; Hilary J Harris; Tracey A Johnston; Elizabeth N Anionwu; Vicki Tsianakas; Patricia Jones; Theresa M Marteau
Journal:  BMJ       Date:  2010-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.